How market wizard Anil Singhvi views Natco Pharma, NALCO, NMDC, other stocks today

The market guru points out that the pharmaceutical company registered a record net profit as well as revenue for the financial year. 

For the quarter ended March 31, Natco Pharma registered year-on-year growth of 40 per cent and 19 per cent in net profit and revenue, respectively, while its margin improved by 870 bps to 46.5 per cent, according to a regulatory filing.

The market wizard suggests buying Natco Pharma shares for targets of Rs 1,040, Rs 1,054 and Rs 1,070 with a stop loss at Rs 1,015.

The market wizard highlights that USL's premiumisation growth story looks strong while the company seems confident of double-digit growth in FY25.

The market guru suggests buying United Spirits futures for targets of Rs 1,180, Rs 1,195 and Rs 1,210 with a stop loss at Rs 1,145.

The market wizard suggests buying Sumitomo Chemical shares for targets of Rs 449, Rs 454 and Rs 460 with a stop loss at Rs 435. 

The market guru points out that Sumitomo Chemical India staged a "very strong" operational performance for the March quarter. 

The chemical manufacturer's margins improved by 830 bps on a year-on-year basis to 20.8 per cent.

The market guru highlights that NALCO shares have already risen 25 per cent in three months and 140 per cent in a year. He expects profit-booking at higher levels in the stock and suggests investors avoid chasing it. 

The stock exited the F&O ban on Tuesday. 

NALCO logged a 94 per cent surge in its standalone net profit to Rs 1,015 crore with 44 per cent growth in its EBITDA for the March quarter. Its quarterly margin, a key measure of profitability, expanded to 31 per cent from 21 per cent a year ago.

The market wizard points out that state-run miner NMDC's quarterly numbers fell short of analysts' expectations on the operational front.

He expects some correction in the stock owing to the company's weak quarterly performance.